Nurse Practitioner, Family · Federal Way, WA
NPI
1942429998
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
34509 9th Ave S, Suite 306
Federal Way, WA, 98003
Phone (253) 838-1520
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,700
37 services
Medicare patients, 2024
28
Average age 67
Drug cost, 2024
$22K
296 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mariya L Gusenkov was code 99214 (office e&m - established), 16 times for 14 patients. In total Mariya L Gusenkov billed 37 services in 4 codes, and Medicare paid $3,700.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 16 | 14 | $92.13 | $1,474 |
| 99204 Office E&M - New | Office | 15 | 15 | $120.17 | $1,803 |
Medicare prescription drug claims, 2024
In 2024, the drug Mariya L Gusenkov prescribed most often to Medicare patients was Estradiol, with 93 prescriptions and refills. In total Mariya L Gusenkov wrote 296 Medicare prescriptions that cost $22K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 93 | 268 | 45 | $5,415 |
| Estradiol (Once Weekly) Estradiol | 66 | 142 | 26 | $7,235 |
| Progesterone Progesterone, Micronized | 42 | 101 | 18 | $1,365 |
| Medroxyprogesterone Acetate Generic | 25 | 70 | Under 11 | $449 |
| Tolterodine Tartrate Generic | 14 | 14 | Under 11 | $710 |
Brand drugs: 57 claims; generic drugs: 239 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mariya L Gusenkov were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.